Literature DB >> 4585428

Neoplasia--what are the prospects of immunological intervention?

B T Rouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4585428      PMCID: PMC1696208     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  10 in total

1.  AN AVIAN LEUCOSIS GROUP-SPECIFIC COMPLEMENT FIXATION REACTION. APPLICATION FOR THE DETECTION AND ASSAY OF NON-CYTOPATHOGENIC LEUCOSIS VIRUSES.

Authors:  P S SARMA; H C TURNER; R J HUEBNER
Journal:  Virology       Date:  1964-07       Impact factor: 3.616

2.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

Review 3.  Immunotherapy of cancer. Present status and future potential.

Authors:  D L Morton
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

Review 4.  Immunological enhancement: a study of blocking antibodies.

Authors:  J D Feldman
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

5.  Immunization against Marek's disease using a live attenuated virus.

Authors:  A E Churchill; L N Payne; R C Chubb
Journal:  Nature       Date:  1969-02-22       Impact factor: 49.962

Review 6.  The cellular basis of immunological responses. A synthesis of some current views.

Authors:  I M Roitt; M F Greaves; G Torrigiani; J Brostoff; J H Playfair
Journal:  Lancet       Date:  1969-08-16       Impact factor: 79.321

7.  Immunological surveillance in neoplasia.

Authors:  F M Burnet
Journal:  Transplant Rev       Date:  1971

8.  Hypersensitivity reactions at tumor sites.

Authors:  E Klein
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.